The Biotech Growth Trust PLC (BIOG) - Total Assets
Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) holds total assets worth GBX289.97 Million GBX (≈ $35.28K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BIOG book value for net asset value and shareholders' equity analysis.
The Biotech Growth Trust PLC - Total Assets Trend (2004–2025)
This chart illustrates how The Biotech Growth Trust PLC's total assets have evolved over time, based on quarterly financial data.
The Biotech Growth Trust PLC - Asset Composition Analysis
Current Asset Composition (March 2025)
The Biotech Growth Trust PLC's total assets of GBX289.97 Million consist of 3.7% current assets and 96.3% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 3.7% |
| Accounts Receivable | GBX0.00 | 0.0% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2004–2025)
This chart illustrates how The Biotech Growth Trust PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BIOG market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: The Biotech Growth Trust PLC's current assets represent 3.7% of total assets in 2025, an increase from 1.0% in 2004.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, up from 0.9% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2004.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
The Biotech Growth Trust PLC Competitors by Total Assets
Key competitors of The Biotech Growth Trust PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
BlackRock Technology and Private Equity Term Trust
NYSE:BTX
|
USA | $938.97 Million |
|
Sprott Physical Silver
TO:PSLV
|
Canada | CA$9.40 Billion |
|
Groep Brussel Lambert NV
BR:GBLB
|
Belgium | €25.54 Billion |
|
Sprott Physical Gold and Silver Trust
TO:CEF
|
Canada | CA$7.31 Billion |
|
Australian Foundation Investment Company Ltd
AU:AFI
|
Australia | AU$9.94 Billion |
|
Argo Investments Ltd
AU:ARG
|
Australia | AU$7.91 Billion |
|
Norte Grande
SN:NORTEGRAN
|
Chile | CL$2.91 Billion |
|
Cuprum
SN:CUPRUM
|
Chile | CL$932.92 Billion |
The Biotech Growth Trust PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 20.91 | 0.32 | 0.07 |
| Quick Ratio | 20.91 | 0.32 | 0.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX8.06 Million | GBX-35.85 Million | GBX-33.12 Million |
The Biotech Growth Trust PLC - Advanced Valuation Insights
This section examines the relationship between The Biotech Growth Trust PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.96 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -44.9% |
| Total Assets | GBX226.63 Million |
| Market Capitalization | $3.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values The Biotech Growth Trust PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: The Biotech Growth Trust PLC's assets decreased by 44.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for The Biotech Growth Trust PLC (2004–2025)
The table below shows the annual total assets of The Biotech Growth Trust PLC from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | GBX226.63 Million ≈ $27.57K |
-44.92% |
| 2024-03-31 | GBX411.42 Million ≈ $50.06K |
+14.12% |
| 2023-03-31 | GBX360.51 Million ≈ $43.86K |
-15.66% |
| 2022-03-31 | GBX427.45 Million ≈ $52.01K |
-34.19% |
| 2021-03-31 | GBX649.53 Million ≈ $79.03K |
+61.90% |
| 2020-03-31 | GBX401.19 Million ≈ $48.81K |
-6.97% |
| 2019-03-31 | GBX431.23 Million ≈ $52.47K |
-3.33% |
| 2018-03-31 | GBX446.07 Million ≈ $54.27K |
-3.34% |
| 2017-03-31 | GBX461.50 Million ≈ $56.15K |
+8.55% |
| 2016-03-31 | GBX425.14 Million ≈ $51.73K |
-27.52% |
| 2015-03-31 | GBX586.53 Million ≈ $71.36K |
+54.17% |
| 2014-03-31 | GBX380.43 Million ≈ $46.29K |
+42.66% |
| 2013-03-31 | GBX266.66 Million ≈ $32.45K |
+64.74% |
| 2012-03-31 | GBX161.87 Million ≈ $19.69K |
+19.73% |
| 2011-03-31 | GBX135.20 Million ≈ $16.45K |
+1.71% |
| 2010-03-31 | GBX132.92 Million ≈ $16.17K |
+78.46% |
| 2009-03-31 | GBX74.48 Million ≈ $9.06K |
+12.06% |
| 2008-03-31 | GBX66.47 Million ≈ $8.09K |
-17.46% |
| 2007-03-31 | GBX80.53 Million ≈ $9.80K |
+106.14% |
| 2006-03-31 | GBX39.07 Million ≈ $4.75K |
+27.08% |
| 2005-03-31 | GBX30.74 Million ≈ $3.74K |
-9.79% |
| 2004-03-31 | GBX34.08 Million ≈ $4.15K |
-- |
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create … Read more